My Companies
Notification
Account
Log Out
Back

Sai Parenterals To Acquire Majority Stake In Bion Therapeutics India


16 November 2026
Sai Parenteral's Ltd.

Board approved SP Analytics signing deal to acquire majority cash stake in Bion Therapeutics, to close by 30 Nov 2026. Bion H1 turnover Rs28.22 Cr. Funding via IPO GCP proceeds and debt. Another small bolt-on after recent injectable and R&D buys, but first branded prescription deal housed in R&D vehicle; extends acquisition-led build alongside export CDMO pivot. Price based on independent valuation and exact stake undisclosed; promoter interest and funding split between GCP and debt not disclosed; related-party assessment pending; closes within two weeks.


Recent Events

Company Information